BUSINESSLupin Slips 4% as Goa Plant Gets USFDA’s ObservationsNeha VermaSeptember 20, 2021September 20, 2021 by Neha VermaSeptember 20, 2021September 20, 202102343 On Monday, Lupin Ltd’s shares dipped 4 per cent to Rs 913 on the BSE in intra-day trade after the pharmaceutical company said on Sunday...
BUSINESSZydus Cadila Gets USFDA Tentative Nod for Epilepsy Treatment DrugNeha VermaJune 14, 2021June 14, 2021 by Neha VermaJune 14, 2021June 14, 202101303 On Monday, Zydus Cadila said that they received tentative approval from the US health regulator to market epilepsy treatment drug Brivaracetam tablets. Zydus Cadila has...
BUSINESSLatest NewsCipla Zooms 14% on USFDA Nod for Generic ProventiladminApril 9, 2020May 19, 2020 by adminApril 9, 2020May 19, 202001330 Cipla Ltd shares have gained as much as 16 per cent after the company received approval from the US Food and Drug Administration (USFDA) for...